Cited by 135Extracellular vesicles in diseaseAmyotrophic Lateral Sclerosis ResearchNeuroinflammation and Neurodegeneration Mechanisms

Exosomes from NSC-34 Cells Transfected with hSOD1-G93A Are Enriched in miR-124 and Drive Alterations in Microglia Phenotype

Open access
Pinto, Sara, Cunha, Carolina, Barbosa, Marta, Vaz, Ana R., Brites, Dora·2017·Frontiers in Neuroscience

Abstract

Amyotrophic lateral sclerosis (ALS) is a fatal adult-onset neurodegenerative disorder affecting motor neurons (MNs). Evidences indicate that ALS is a non-cell autonomous disease in which glial cells participate in both disease onset and progression. Exosomal transfer of mutant copper-zinc superoxide dismutase 1 (mSOD1) from cell-to-cell was suggested to contribute to disease dissemination. Data from our group and others showed that exosomes from activated cells contain inflammatory-related microRNAs (inflamma-miRNAs) that recapitulate the donor cell. While glia-derived exosomes and their effects in neurons have been addressed by several studies, only a few investigated the influence of motor neuron (MN)-derived exosomes in other cell function, the aim of the present study. We assessed a set of inflamma-miRs in NSC-34 MN-like cells transfected with mutant SOD1(G93A) and extended the study into their derived exosomes (mSOD1 exosomes). Then, the effects produced by mSOD1 exosomes in the activation and polarization of the recipient N9 microglial cells were investigated. Exosomes in coculture with N9 microglia and NSC-34 cells [either transfected with either wild-type (wt) human SOD1 or mutant SOD1(G93A)] showed to be transferred into N9 cells. Increased miR-124 expression was found in mSOD1 NSC-34 cells and in their derived exosomes. Incubation of mSOD1 exosomes with N9 cells determined a sustained 50% reduction in the cell phagocytic ability. It also caused a persistent NF-kB activation and an acute generation of NO, MMP-2, and MMP-9 activation, as well as upregulation of IL-1β, TNF-α, MHC-II, and iNOS gene expression, suggestive of induced M1 polarization. Marked elevation of IL-10, Arginase 1, TREM2, RAGE, and TLR4 mRNA levels, together with increased miR-124, miR-146a, and miR-155, at 24 h incubation, suggest the switch to mixed M1 and M2 subpopulations in the exosome-treated N9 microglial cells. Exosomes from mSOD1 NSC-34 MNs also enhanced the number of senescent-like positive N9 cells. Data suggest that miR-124 is translocated from the mSOD1 MNs to exosomes, which determine early and late phenotypic alterations in the recipient N9-microglial cells. In conclusion, modulation of the inflammatory-associated miR-124, in mSOD1 NSC-34 MNs, with potential benefits in the cargo of their exosomes may reveal a promising therapeutic strategy in halting microglia activation and associated effects in MN degeneration.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fnins.2017.00273

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • miRNAs can be released by cells as free species directly into their secretome or selectively enriched in exosomes (diameter <150 nm) that, when internalized by target cells, affect their biological functions.

    “In general, miRNAs can be released by cells as free species directly into their secretome or selectively enriched in small extracellular vesicles (exosomes, diameter size <150 nm) that, when internalized by target cells, affect their biological functions [38,39,40,41].”

    From Emerging Role of miR-21-5p in Neuron–Glia Dysregulation and Exosome Transfer Using Multiple Models of Alzheimer’s Disease (2022) · cites this paper as [38]

    The Results report miR-124 enrichment in exosomes from mSOD1 cells and describe those exosomes as averaging about 130 nm in diameter. The Results also state that exosomal miRNAs can enter recipient cells and change their function. Our copy does not establish the alternative claim that cells release free miRNAs directly into their secretome, or define all exosomes as smaller than 150 nm. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 107

  1. Abiega O. Beccari S. Diaz-Aparicio I. Nadjar A. Laye S. Leyrolle Q. (2016). Neuronal hyperactivity disturbs ATP microgradients, impairs microglial motility, and reduces phagocytic receptor expression triggering apoptosis/microglial phagocytosis uncoupling. PLoS Biol. 14: e1002466 10.1371/journal.pbio.1002466 27228556 PMC4881984 · DOI
  2. Alexander M. Hu R. Runtsch M. C. Kagele D. A. Mosbruger T. L. Tolmachova T.. (2015). Exosome-delivered microRNAs modulate the inflammatory response to endotoxin. Nat. Commun. 6: 7321. 10.1038/ncomms8321 26084661 PMC4557301 · DOI · Paper page
  3. Aryani A. Denecke B. (2016). Exosomes as a nanodelivery system: a key to the future of neuromedicine? Mol. Neurobiol. 53, 818– 834. 10.1007/s12035-014-9054-5 25502465 PMC4752585 · DOI
  4. Baixauli F. Lopez-Otin C. Mittelbrunn M. (2014). Exosomes and autophagy: coordinated mechanisms for the maintenance of cellular fitness. Front. Immunol. 5: 403. 10.3389/fimmu.2014.00403 25191326 PMC4138502 · DOI
  5. Basso M. Bonetto V. (2016). Extracellular vesicles and a novel form of communication in the brain. Front. Neurosci. 10: 127. 10.3389/fnins.2016.00127 27065789 PMC4814526 · DOI
  6. Basso M. Pozzi S. Tortarolo M. Fiordaliso F. Bisighini C. Pasetto L.. (2013). Mutant copper-zinc superoxide dismutase (SOD1) induces protein secretion pathway alterations and exosome release in astrocytes: implications for disease spreading and motor neuron pathology in amyotrophic lateral sclerosis. J. Biol. Chem. 288, 15699– 15711. 10.1074/jbc.M112.425066 23592792 PMC3668729 · DOI
  7. Bertheloot D. Naumovski A. L. Langhoff P. Horvath G. L. Jin T. Xiao T. S.. (2016). RAGE Enhances TLR Responses through Binding and Internalization of RNA. J. Immunol. 197, 4118– 4126. 10.4049/jimmunol.1502169 27798148 PMC6062438 · DOI
  8. Bonnay F. Nguyen X. H. Cohen-Berros E. Troxler L. Batsche E. Camonis J. (2014). Akirin specifies NF-κB selectivity of Drosophila innate immune response via chromatin remodeling. EMBO J. 33, 2349– 2362. 10.15252/embj.201488456 25180232 PMC4253524 · DOI
  9. Bretz N. P. Ridinger J. Rupp A. K. Rimbach K. Keller S. Rupp C.. (2013). Body fluid exosomes promote secretion of inflammatory cytokines in monocytic cells via Toll-like receptor signaling. J. Biol. Chem. 288, 36691– 36702. 10.1074/jbc.M113.512806 24225954 PMC3868779 · DOI
  10. Brites D. Vaz A. R. (2014). Microglia centered pathogenesis in ALS: insights in cell interconnectivity. Front. Cell. Neurosci. 8: 117 10.3389/fncel.2014.00117 24904276 PMC4033073 · DOI
  11. Budnik V. Ruiz-Canada C. Wendler F. (2016). Extracellular vesicles round off communication in the nervous system. Nat. Rev. Neurosci. 17, 160– 172. 10.1038/nrn.2015.29 26891626 PMC4989863 · DOI · Paper page
  12. Cady J. Koval E. D. Benitez B. A. Zaidman C. Jockel-Balsarotti J. Allred P. (2014). TREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosis. JAMA Neurol. 71, 449– 453. 10.1001/jamaneurol.2013.6237 24535663 PMC4087113 · DOI · Paper page
  13. Caldeira C. Oliveira A. F. Cunha C. Vaz A. R. Falcão A. S. Fernandes A. (2014). Microglia change from a reactive to an age-like phenotype with the time in culture. Front. Cell. Neurosci. 8: 152 10.3389/fncel.2014.00152 24917789 PMC4040822 · DOI · Paper page
  14. Cashman N. R. Durham H. D. Blusztajn J. K. Oda K. Tabira T. Shaw I. T.. (1992). Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev. Dyn. 194, 209– 221. 10.1002/aja.1001940306 1467557 · DOI
  15. Chen S. M. Chou W. C. Hu L. Y. Hsiung C. N. Chu H. W. Huang Y. L.. (2015). The effect of microRNA-124 overexpression on anti-tumor drug sensitivity. PLoS ONE 10: e0128472. 10.1371/journal.pone.0128472 26115122 PMC4482746 · DOI
  16. Chhor V. Le Charpentier T. Lebon S. Oré M.-V. Celador I. L. Josserand J.. (2013). Characterization of phenotype markers and neuronotoxic potential of polarised primary microglia in vitro. Brain Behav. Immun. 32, 70– 85. 10.1016/j.bbi.2013.02.005 23454862 PMC3694309 · DOI
  17. Chiu I. M. Morimoto E. T. Goodarzi H. Liao J. T. O'Keeffe S. Phatnani H. P.. (2013). A neurodegeneration-specific gene-expression signature of acutely isolated microglia from an amyotrophic lateral sclerosis mouse model. Cell Rep. 4, 385– 401. 10.1016/j.celrep.2013.06.018 23850290 PMC4272581 · DOI · Paper page
  18. Cho G. W. Kim G. Y. Baek S. Kim H. Kim T. Kim H. J.. (2011). Recombinant human erythropoietin reduces aggregation of mutant Cu/Zn-binding superoxide dismutase (SOD1) in NSC-34 cells. Neurosci. Lett. 504, 107– 111. 10.1016/j.neulet.2011.09.008 21945651 · DOI
  19. Cunha C. Gomes C. Vaz A. R. Brites D. (2016). Exploring new inflammatory biomarkers and pathways during LPS-induced M1 polarization. Mediat. Inflamm. 2016: 6986175 10.1155/2016/6986175 PMC5209629 28096568 · DOI · Paper page
  20. Debacq-Chainiaux F. Erusalimsky J. D. Campisi J. Toussaint O. (2009). Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo. Nat. Protoc. 4, 1798– 1806. 10.1038/nprot.2009.191 20010931 · DOI · Paper page
  21. Deng T. Feng X. Liu P. Yan K. Chen Y. Han D. (2013). Toll-like receptor 3 activation differentially regulates phagocytosis of bacteria and apoptotic neutrophils by mouse peritoneal macrophages. Immunol. Cell Biol. 91, 52– 59. 10.1038/icb.2012.45 22986631 · DOI · Paper page
  22. Drechsel D. A. Estévez A. G. Barbeito L. Beckman J. S. (2012). Nitric oxide-mediated oxidative damage and the progressive demise of motor neurons in ALS. Neurotox. Res. 22, 251– 264. 10.1007/s12640-012-9322-y 22488161 PMC4145402 · DOI
  23. Durafourt B. A. Moore C. S. Zammit D. A. Johnson T. A. Zaguia F. Guiot M. C.. (2012). Comparison of polarization properties of human adult microglia and blood-derived macrophages. Glia 60, 717– 727. 10.1002/glia.22298 22290798 · DOI
  24. Dutta S. Warshall C. Bandyopadhyay C. Dutta D. Chandran B. (2014). Interactions between exosomes from breast cancer cells and primary mammary epithelial cells leads to generation of reactive oxygen species which induce DNA damage response, stabilization of p53 and autophagy in epithelial cells. PLoS ONE 9, e97580– e97580. 10.1371/journal.pone.0097580 24831807 PMC4022578 · DOI
  25. Falcão A. S. Carvalho L. A. Lidónio G. Vaz A. R. Lucas S. D. Moreira R.. (2017). Dipeptidyl Vinyl Sulfone as a Novel Chemical Tool to Inhibit HMGB1/NLRP3-Inflammasome and Inflamma-miRs in Abeta-Mediated Microglial Inflammation. ACS Chem. Neurosci. 8, 89– 99. 10.1021/acschemneuro.6b00250 27797173 · DOI
  26. Fang L. Teuchert M. Huber-Abel F. Schattauer D. Hendrich C. Dorst J.. (2010). MMP-2 and MMP-9 are elevated in spinal cord and skin in a mouse model of ALS. J. Neurol. Sci. 294, 51– 56. 10.1016/j.jns.2010.04.005 20441996 · DOI
  27. Feng X. Deng T. Zhang Y. Su S. Wei C. Han D. (2011). Lipopolysaccharide inhibits macrophage phagocytosis of apoptotic neutrophils by regulating the production of tumour necrosis factor alpha and growth arrest-specific gene 6. Immunology 132, 287– 295. 10.1111/j.1365-2567.2010.03364.x 21039473 PMC3050451 · DOI
  28. Fernandes A. Falcão A. S. Silva R. F. Gordo A. C. Gama M. J. Brito M. A.. (2006). Inflammatory signalling pathways involved in astroglial activation by unconjugated bilirubin. J. Neurochem. 96, 1667– 1679. 10.1111/j.1471-4159.2006.03680.x 16476078 · DOI
  29. Fitzner D. Schnaars M. van Rossum D. Krishnamoorthy G. Dibaj P. Bakhti M.. (2011). Selective transfer of exosomes from oligodendrocytes to microglia by macropinocytosis. J. Cell Sci. 124, 447– 458. 10.1242/jcs.074088 21242314 · DOI · Paper page
  30. Fleisher-Berkovich S. Filipovich-Rimon T. Ben-Shmuel S. Hulsmann C. Kummer M. P. Heneka M. T. (2010). Distinct modulation of microglial amyloid beta phagocytosis and migration by neuropeptides (i). J. Neuroinflammation 7: 61. 10.1186/1742-2094-7-61 20937084 PMC2964654 · DOI
  31. Frakes A. E. Ferraiuolo L. Haidet-phillips A. M. Schmelzer L. Braun L. Miranda C. J.. (2014). Microglia induce motor neuron death via the classical NF-κB pathway in amyotrophic lateral sclerosis. Neuron 81, 1009– 1023. 10.1016/j.neuron.2014.01.013 24607225 PMC3978641 · DOI · Paper page
  32. Freilich R. W. Woodbury M. E. Ikezu T. (2013). Integrated expression profiles of mRNA and miRNA in polarized primary murine microglia. PLoS ONE 8: e79416. 10.1371/journal.pone.0079416 24244499 PMC3823621 · DOI · Paper page
  33. Fu R. Shen Q. Xu P. Luo J. J. Tang Y. (2014). Phagocytosis of microglia in the central nervous system diseases. Mol. Neurobiol. 49, 1422– 1434. 10.1007/s12035-013-8620-6 24395130 PMC4012154 · DOI
  34. Fujita K. Motoki K. Tagawa K. Chen X. Hama H. Nakajima K. (2016). HMGB1, a pathogenic molecule that induces neurite degeneration via TLR4-MARCKS, is a potential therapeutic target for Alzheimer's disease. Sci. Rep. 6: 31895 10.1038/srep31895 27557632 PMC4997258 · DOI · Paper page
  35. Gao H. M. Zhou H. Zhang F. Wilson B. C. Kam W. Hong J. S. (2011). HMGB1 acts on microglia Mac1 to mediate chronic neuroinflammation that drives progressive neurodegeneration. J. Neurosci. 31, 1081– 1092. 10.1523/JNEUROSCI.3732-10.2011 21248133 PMC3046932 · DOI · Paper page
  36. Gerber Y. N. Sabourin J. C. Rabano M. Vivanco M. Perrin F. E. (2012). Early functional deficit and microglial disturbances in a mouse model of amyotrophic lateral sclerosis. PLoS ONE 7: e36000. 10.1371/journal.pone.0036000 22558300 PMC3338492 · DOI
  37. Ghosh S. May M. J. Kopp E. B. (1998). NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16, 225– 260. 10.1146/annurev.immunol.16.1.225 9597130 · DOI
  38. Goldmann T. Prinz M. (2013). Role of microglia in CNS autoimmunity. Clin. Dev. Immunol. 2013: 208093. 10.1155/2013/208093 23840238 PMC3694374 · DOI
  39. Gowing G. Philips T. Van Wijmeersch B. Audet J. N. Dewil M. Van Den Bosch L. (2008). Ablation of proliferating microglia does not affect motor neuron degeneration in amyotrophic lateral sclerosis caused by mutant superoxide dismutase. J. Neurosci. 28, 10234– 10244. 10.1523/JNEUROSCI.3494-08.2008 18842883 PMC6671032 · DOI
  40. Grad L. I. Pokrishevsky E. Silverman J. M. Cashman N. R. (2014a). Exosome-dependent and independent mechanisms are involved in prion-like transmission of propagated Cu/Zn superoxide dismutase misfolding. Prion 8, 331– 335. 10.4161/19336896.2014.983398 25551548 PMC4601269 · DOI
  41. Grad L. I. Yerbury J. J. Turner B. J. Guest W. C. Pokrishevsky E. O'Neill M. A.. (2014b). Intercellular propagated misfolding of wild-type Cu/Zn superoxide dismutase occurs via exosome-dependent and -independent mechanisms. Proc. Natl. Acad. Sci. U.S.A. 111, 3620– 3625. 10.1073/pnas.1312245111 24550511 PMC3948312 · DOI
  42. Gupta A. Pulliam L. (2014). Exosomes as mediators of neuroinflammation. J. Neuroinflammation 11: 68. 10.1186/1742-2094-11-68 24694258 PMC3994210 · DOI
  43. Hooten K. G. Beers D. R. Zhao W. Appel S. H. (2015). Protective and toxic neuroinflammation in amyotrophic lateral sclerosis. Neurotherapeutics 12, 364– 375. 10.1007/s13311-014-0329-3 25567201 PMC4404435 · DOI
  44. Im H. I. Kenny P. J. (2012). MicroRNAs in neuronal function and dysfunction. Trends Neurosci. 35, 325– 334. 10.1016/j.tins.2012.01.004 22436491 PMC3565236 · DOI · Paper page
  45. Ji Q. Ji Y. Peng J. Zhou X. Chen X. Zhao H.. (2016). Increased brain-specific MiR-9 and MiR-124 in the serum exosomes of acute ischemic stroke patients. PLoS ONE 11: e0163645. 10.1371/journal.pone.0163645 27661079 PMC5035015 · DOI
  46. Jiang M. Xiang Y. Wang D. Gao J. Liu D. Liu Y.. (2012). Dysregulated expression of miR-146a contributes to age-related dysfunction of macrophages. Aging Cell. 11, 29– 40. 10.1111/j.1474-9726.2011.00757.x 21981419 · DOI
  47. Jiang T. Tan L. Zhu X. C. Zhang Q. Q. Cao L. Tan M. S.. (2014). Upregulation of TREM2 ameliorates neuropathology and rescues spatial cognitive impairment in a transgenic mouse model of Alzheimer's disease. Neuropsychopharmacology 39, 2949– 2962. 10.1038/npp.2014.164 25047746 PMC4229581 · DOI · Paper page
  48. Juranek J. K. Daffu G. K. Geddis M. S. Li H. Rosario R. Kaplan B. J. (2016). Soluble RAGE treatment delays progression of amyotrophic lateral sclerosis in SOD1 mice. Front. Cell. Neurosci. 10: 117 10.3389/fncel.2016.00117 27242430 PMC4860390 · DOI
  49. Juranek J. K. Daffu G. K. Wojtkiewicz J. Lacomis D. Kofler J. Schmidt A. M. (2015). Receptor for advanced glycation end products and its inflammatory ligands are upregulated in amyotrophic lateral sclerosis. Front. Cell. Neurosci. 9: 485. 10.3389/fncel.2015.00485 26733811 PMC4686801 · DOI · Paper page
  50. Kloss C. U. A. Bohatschek M. Kreutzberg G. W. Raivich G. (2001). Effect of lipopolysaccharide on the morphology and integrin immunoreactivity of ramified microglia in the mouse brain and in cell culture. Exp. Neurol. 168, 32– 46. 10.1006/exnr.2000.7575 11170719 · DOI
  51. Korkut C. Li Y. Koles K. Brewer C. Ashley J. Yoshihara M. (2013). Regulation of postsynaptic retrograde signaling by presynaptic exosome release. Neuron 77, 1039– 1046. 10.1016/j.neuron.2013.01.013 23522040 PMC3626103 · DOI · Paper page
  52. Koval E. D. Shaner C. Zhang P. du Maine X. Fischer K. Tay J.. (2013). Method for widespread microRNA-155 inhibition prolongs survival in ALS-model mice. Hum. Mol. Genet. 22, 4127– 4135. 10.1093/hmg/ddt261 23740943 PMC3781640 · DOI · Paper page
  53. Krichevsky A. M. Sonntag K. C. Isacson O. Kosik K. S. (2006). Specific microRNAs modulate embryonic stem cell-derived neurogenesis. Stem Cells. 24, 857– 864. 10.1634/stemcells.2005-0441 16357340 PMC2605651 · DOI · Paper page
  54. Kruger S. Battke F. Sprecher A. Munz M. Synofzik M. Schols L.. (2016). Rare variants in neurodegeneration associated genes revealed by targeted panel sequencing in a German ALS Cohort. Front. Mol. Neurosci. 9: 92. 10.3389/fnmol.2016.00092 27790088 PMC5061735 · DOI
  55. Kye M. J. Goncalves Ido C. (2014). The role of miRNA in motor neuron disease. Front. Cell. Neurosci. 8: 15. 10.3389/fncel.2014.00015 24523674 PMC3906579 · DOI
  56. Lee J. Hyeon S. J. Im H. Ryu H. Kim Y. (2016). Astrocytes and microglia as non-cell autonomous players in the pathogenesis of ALS. Exp. Neurobiol. 25, 233– 240. 10.5607/en.2016.25.5.233 27790057 PMC5081469 · DOI
  57. Lee J. Y. Lee J. D. Phipps S. Noakes P. G. Woodruff T. M. (2015). Absence of toll-like receptor 4 (TLR4) extends survival in the hSOD1 G93A mouse model of amyotrophic lateral sclerosis. J. Neuroinflammation 12: 90. 10.1186/s12974-015-0310-z 25962427 PMC4431460 · DOI · Paper page
  58. Li Z. Qin T. Wang K. Hackenberg M. Yan J. Gao Y.. (2015). Integrated microRNA, mRNA, and protein expression profiling reveals microRNA regulatory networks in rat kidney treated with a carcinogenic dose of aristolochic acid. BMC Genomics 16: 365. 10.1186/s12864-015-1516-2 25952319 PMC4456708 · DOI
  59. Lim G. P. Backstrom J. R. Cullen M. J. Miller C. A. Atkinson R. D. Tökés Z. A. (1996). Matrix metalloproteinases in the neocortex and spinal cord of amyotrophic lateral sclerosis patients. J. Neurochem. 67, 251– 259. 10.1046/j.1471-4159.1996.67010251.x 8666998 · DOI
  60. Liu G. Abraham E. (2013). MicroRNAs in immune response and macrophage polarization. Arterioscler. Thromb. Vasc. Biol. 33, 170– 177. 10.1161/ATVBAHA.112.300068 23325473 PMC3549532 · DOI
  61. Lo Coco D. Veglianese P. Allievi E. Bendotti C. (2007). Distribution and cellular localization of high mobility group box protein 1 (HMGB1) in the spinal cord of a transgenic mouse model of ALS. Neurosci. Lett. 412, 73– 77. 10.1016/j.neulet.2006.10.063 17196331 · DOI
  62. Lu B. Wang H. Andersson U. Tracey K. J. (2013). Regulation of HMGB1 release by inflammasomes. Protein Cell 4, 163– 167. 10.1007/s13238-012-2118-2 23483477 PMC4533838 · DOI
  63. Madison R. D. McGee C. Rawson R. Robinson G. A. (2014). Extracellular vesicles from a muscle cell line (C2C12) enhance cell survival and neurite outgrowth of a motor neuron cell line (NSC-34). J. Extracell. Vesicles 3. 10.3402/jev.v3.22865 24563732 PMC3930942 · DOI
  64. Makeyev E. V. Zhang J. Carrasco M. A. Maniatis T. (2007). The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. Mol. Cell. 27, 435– 448. 10.1016/j.molcel.2007.07.015 17679093 PMC3139456 · DOI · Paper page
  65. Maniecka Z. Polymenidou M. (2015). From nucleation to widespread propagation: a prion-like concept for ALS. Virus Res. 207, 94– 105. 10.1016/j.virusres.2014.12.032 25656065 · DOI
  66. Matsumoto K. Morisaki T. Kuroki H. Kubo M. Onishi H. Nakamura K.. (2005). Exosomes secreted from monocyte-derived dendritic cells support in vitro naive CD4+ T cell survival through NF-(kappa)B activation. Cell. Immunol. 231, 20– 29. 10.1016/j.cellimm.2004.11.002 15919366 · DOI
  67. Morel L. Regan M. Higashimori H. Ng S. K. Esau C. Vidensky S.. (2013). Neuronal exosomal miRNA-dependent translational regulation of astroglial glutamate transporter GLT1. J. Biol. Chem. 288, 7105– 7116. 10.1074/jbc.M112.410944 23364798 PMC3591620 · DOI · Paper page
  68. Nakamura Y. Si Q. S. Kataoka K. (1999). Lipopolysaccharide-induced microglial activation in culture: temporal profiles of morphological change and release of cytokines and nitric oxide. Neurosci. Res. 35, 95– 100. 10.1016/S0168-0102(99)00071-1 10616913 · DOI
  69. Neo W. H. Yap K. Lee S. H. Looi L. S. Khandelia P. Neo S. X.. (2014). MicroRNA miR-124 controls the choice between neuronal and astrocyte differentiation by fine-tuning Ezh2 expression. J. Biol. Chem. 289, 20788– 20801. 10.1074/jbc.M113.525493 24878960 PMC4110287 · DOI
  70. Nikodemova M. Small A. L. Smith S. M. Mitchell G. S. Watters J. J. (2014). Spinal but not cortical microglia acquire an atypical phenotype with high VEGF, galectin-3 and osteopontin, and blunted inflammatory responses in ALS rats. Neurobiol. Dis. 69, 43– 53. 10.1016/j.nbd.2013.11.009 24269728 PMC4079765 · DOI
  71. Nikodemova M. Watters J. J. (2011). Outbred ICR/CD1 mice display more severe neuroinflammation mediated by microglial TLR4/CD14 activation than inbred C57Bl/6 mice. Neuroscience 190, 67– 74. 10.1016/j.neuroscience.2011.06.006 21683771 PMC3156380 · DOI
  72. Olivieri F. Lazzarini R. Recchioni R. Marcheselli F. Rippo M. R. Di Nuzzo S.. (2013). MiR-146a as marker of senescence-associated pro-inflammatory status in cells involved in vascular remodelling. Age (Dordr). 35, 1157– 1172. 10.1007/s11357-012-9440-8 22692818 PMC3705128 · DOI
  73. Onyeagucha B. C. Mercado-Pimentel M. E. Hutchison J. Flemington E. K. Nelson M. A. (2013). S100P/RAGE signaling regulates microRNA-155 expression via AP-1 activation in colon cancer. Exp. Cell Res. 319, 2081– 2090. 10.1016/j.yexcr.2013.05.009 23693020 PMC3726211 · DOI
  74. Parisi C. Arisi I. D'Ambrosi N. Storti A. E. Brandi R. D'Onofrio M.. (2013). Dysregulated microRNAs in amyotrophic lateral sclerosis microglia modulate genes linked to neuroinflammation. Cell Death Dis. 4: e959. 10.1038/cddis.2013.491 24336079 PMC3877562 · DOI
  75. Phatnani H. P. Guarnieri P. Friedman B. A. Carrasco M. A. Muratet M. O'Keeffe S.. (2013). Intricate interplay between astrocytes and motor neurons in ALS. Proc. Natl. Acad. Sci. U.S.A. 110, E756– E765. 10.1073/pnas.1222361110 23388633 PMC3581928 · DOI
  76. Pocock J. M. Kettenmann H. (2007). Neurotransmitter receptors on microglia. Trends Neurosci. 30, 527– 535. 10.1016/j.tins.2007.07.007 17904651 · DOI · Paper page
  77. Righi M. Mori L. De Libero G. Sironi M. Biondi A. Mantovani A.. (1989). Monokine production by microglial cell clones. Eur. J. Immunol. 19, 1443– 1448. 10.1002/eji.1830190815 2789141 · DOI
  78. Roberts K. Zeineddine R. Corcoran L. Li W. Campbell I. L. Yerbury J. J. (2013). Extracellular aggregated Cu/Zn superoxide dismutase activates microglia to give a cytotoxic phenotype. Glia 61, 409– 419. 10.1002/glia.22444 23281114 · DOI
  79. Saba R. Schratt G. M. (2010). MicroRNAs in neuronal development, function and dysfunction. Brain Res. 1338, 3– 13. 10.1016/j.brainres.2010.03.107 20380818 · DOI
  80. Sanuki R. Onishi A. Koike C. Muramatsu R. Watanabe S. Muranishi Y.. (2011). miR-124a is required for hippocampal axogenesis and retinal cone survival through Lhx2 suppression. Nat. Neurosci. 14, 1125– 1134. 10.1038/nn.2897 21857657 · DOI
  81. Sbai O. Ferhat L. Bernard A. Gueye Y. Ould-Yahoui A. Thiolloy S.. (2008). Vesicular trafficking and secretion of matrix metalloproteinases-2, -9 and tissue inhibitor of metalloproteinases-1 in neuronal cells. Mol. Cell. Neurosci. 39, 549– 568. 10.1016/j.mcn.2008.08.004 18817873 · DOI
  82. Schiera G. Di Liegro C. M. Di Liegro I. (2015). Extracellular membrane vesicles as vehicles for brain cell-to-cell interactions in physiological as well as pathological conditions. Biomed Res. Int. 2015: 152926. 10.1155/2015/152926 26583089 PMC4637152 · DOI
  83. Sen R. Smale S. T. (2010). Selectivity of the NF-{kappa}B response. Cold Spring Harb. Perspect. Biol. 2: a000257 10.1101/cshperspect.a000257 20452937 PMC2845200 · DOI
  84. Shen M. Lu J. Dai W. Wang F. Xu L. Chen K.. (2013). Ethyl pyruvate ameliorates hepatic ischemia-reperfusion injury by inhibiting intrinsic pathway of apoptosis and autophagy. Mediat. Inflamm. 2013: 461536. 10.1155/2013/461536 24453420 PMC3886226 · DOI
  85. Shibata N. Hirano A. Hedley-Whyte E. T. Dal Canto M. C. Nagai R. Uchida K. (2002). Selective formation of certain advanced glycation end products in spinal cord astrocytes of humans and mice with superoxide dismutase-1 mutation. Acta Neuropathol. 104, 171– 178. 10.1007/s00401-002-0537-5 12111360 · DOI
  86. Shih R. H. Wang C. Y. Yang C. M. (2015). NF-kappaB signaling pathways in neurological inflammation: a mini review. Front. Mol. Neurosci. 8: 77. 10.3389/fnmol.2015.00077 26733801 PMC4683208 · DOI
  87. Silva S. L. Osório C. Vaz A. R. Barateiro A. Falcão A. S. Silva R. F. M.. (2011). Dynamics of neuron-glia interplay upon exposure to unconjugated bilirubin. J. Neurochem. 117, 412– 424. 10.1111/j.1471-4159.2011.07200.x 21275990 · DOI
  88. Silva S. L. Vaz A. R. Barateiro A. Falcão A. S. Fernandes A. Brito M. A. (2010). Features of bilirubin-induced reactive microglia: from phagocytosis to inflammation. Neurobiol. Dis. 40, 663– 675. 10.1016/j.nbd.2010.08.010 20727973 · DOI
  89. Silverman J. M. Fernando S. M. Grad L. I. Hill A. F. Turner B. J. Yerbury J. J.. (2016). Disease mechanisms in ALS: misfolded SOD1 transferred through exosome-dependent and exosome-independent pathways. Cell. Mol. Neurobiol. 36, 377– 381. 10.1007/s10571-015-0294-3 26908139 PMC11482315 · DOI
  90. Stefano L. Racchetti G. Bianco F. Passini N. Gupta R. S. Panina Bordignon P.. (2009). The surface-exposed chaperone, Hsp60, is an agonist of the microglial TREM2 receptor. J. Neurochem. 110, 284– 294. 10.1111/j.1471-4159.2009.06130.x 19457124 · DOI
  91. Sunden-Cullberg J. Norrby-Teglund A. Rouhiainen A. Rauvala H. Herman G. Tracey K. J.. (2005). Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock. Crit. Care Med. 33, 564– 573. 10.1097/01.CCM.0000155991.88802.4D 15753748 · DOI
  92. Taraboletti G. D'Ascenzo S. Borsotti P. Giavazzi R. Pavan A. Dolo V. (2002). Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells. Am. J. Pathol. 160, 673– 680. 10.1016/S0002-9440(10)64887-0 11839588 PMC1850663 · DOI
  93. Tian B. Nowak D. E. Brasier A. R. (2005). A TNF-induced gene expression program under oscillatory NF-kappaB control. BMC Genomics. 6: 137. 10.1186/1471-2164-6-137 16191192 PMC1262712 · DOI
  94. Valadi H. Ekström K. Bossios A. Sjöstrand M. Lee J. J. Lötvall J. O. (2007). Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654– 659. 10.1038/ncb1596 17486113 · DOI · Paper page
  95. Vaz A. R. Cunha C. Gomes C. Schmucki N. Barbosa M. Brites D. (2015). Glycoursodeoxycholic acid reduces matrix metalloproteinase-9 and caspase-9 activation in a cellular model of superoxide dismutase-1 neurodegeneration. Mol. Neurobiol. 51, 864– 877. 10.1007/s12035-014-8731-8 24848512 · DOI
  96. Veremeyko T. Siddiqui S. Sotnikov I. Yung A. Ponomarev E. D. (2013). IL-4/IL-13-dependent and independent expression of miR-124 and its contribution to M2 phenotype of monocytic cells in normal conditions and during allergic inflammation. PLoS ONE 8: e81774. 10.1371/journal.pone.0081774 24358127 PMC3864800 · DOI · Paper page
  97. Villadangos J. A. Cardoso M. Steptoe R. J. van Berkel D. Pooley J. Carbone F. R.. (2001). MHC class II expression is regulated in dendritic cells independently of invariant chain degradation. Immunity 14, 739– 749. 10.1016/S1074-7613(01)00148-0 11420044 · DOI
  98. Visvanathan J. Lee S. Lee B. Lee J. W. Lee S. K. (2007). The microRNA miR-124 antagonizes the anti-neural REST/SCP1 pathway during embryonic CNS development. Genes Dev. 21, 744– 749. 10.1101/gad.1519107 17403776 PMC1838526 · DOI · Paper page
  99. Woodbury M. E. Freilich R. W. Cheng C. J. Asai H. Ikezu S. Boucher J. D.. (2015). miR-155 is essential for inflammation-induced hippocampal neurogenic dysfunction. J. Neurosci. 35, 9764– 9781. 10.1523/JNEUROSCI.4790-14.2015 26134658 PMC4571507 · DOI
  100. Xu Z. Ho S. Chang C. C. Liu Z. Li M. Vasilescu E. R.. (2014). ILT3.Fc inhibits the production of exosomes containing inflammatory microRNA in supernatants of alloactivated T cells. Hum. Immunol. 75, 756– 759. 10.1016/j.humimm.2014.05.006 24862932 · DOI
  101. Yu J. Y. Chung K. H. Deo M. Thompson R. C. Turner D. L. (2008). MicroRNA miR-124 regulates neurite outgrowth during neuronal differentiation. Exp. Cell Res. 314, 2618– 2633. 10.1016/j.yexcr.2008.06.002 18619591 PMC2702206 · DOI
  102. Yu M. Wang H. Ding A. Golenbock D. T. Latz E. Czura C. J.. (2006). HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock 26, 174– 179. 10.1097/01.shk.0000225404.51320.82 16878026 · DOI · Paper page
  103. Yuyama K. Sun H. Mitsutake S. Igarashi Y. (2012). Sphingolipid-modulated exosome secretion promotes clearance of amyloid-beta by microglia. J. Biol. Chem. 287, 10977– 10989. 10.1074/jbc.M111.324616 22303002 PMC3322859 · DOI
  104. Zhao W. Beers D. R. Appel S. H. (2013). Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis. J. Neuroimmune Pharmacol. 8, 888– 899. 10.1007/s11481-013-9489-x 23881705 PMC4126425 · DOI
  105. Zhu H. Bhattacharyya B. J. Lin H. Gomez C. M. (2013). Skeletal muscle calpain acts through nitric oxide and neural miRNAs to regulate acetylcholine release in motor nerve terminals. J. Neurosci. 33, 7308– 7324. 10.1523/JNEUROSCI.0224-13.2013 23616539 PMC3753772 · DOI · Paper page
  106. Zhu Y. Hou H. Rezai-Zadeh K. Giunta B. Ruscin A. Gemma C.. (2011). CD45 deficiency drives amyloid-beta peptide oligomers and neuronal loss in Alzheimer's disease mice. J. Neurosci. 31, 1355– 1365. 10.1523/JNEUROSCI.3268-10.2011 21273420 PMC3068193 · DOI
  107. Zondler L. Feiler M. S. Freischmidt A. Ruf W. P. Ludolph A. C. Danzer K. M.. (2017). Impaired activation of ALS monocytes by exosomes. Immunol. Cell Biol. 95, 207– 214. 10.1038/icb.2016.89 27616750 · DOI

Cited by

Sorted by citations

Authors
Pinto, S., Cunha, C., Barbosa, M., Vaz, A. R., & Brites, D.
Affiliations
University of Lisbon (PT)
Corresponding author
Brites, Dora
Venue
Frontiers in Neuroscience
Published
2017-05-17
Volume
11
Pages
273-273
ISSN
1662-453X (ISSN-L)
OpenAlex
W2615003101
Cited by
135
References
21
Citations by year
2026: 5 · 2025: 9 · 2024: 16 · 2023: 12 · 2022: 21 · 2021: 27 · 2020: 20 · 2019: 10 · 2018: 12 · 2017: 3
FWCI
5.03
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Frontiers in Neuroscience (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Fundação para a Ciência e a Tecnologia (EU Joint Programme - Neurodegenerative Disease Research (JPND) MADGIC project (JPco-fuND/0003/2015), UID/DTP/04138/2013, SFRH/BPD/76590/2011, SFRH/BD/91316/2012)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
amyotrophic lateral sclerosis, exosomes, miR-124, mutant SOD1, microglial polarization, M1/M2 microglia, neuroinflammation, miR-146a, miR-155, miR-100, miR-101, miR-103, miR-107, miR-122, miR-125b, miR-133, miR-145, miR-148a, miR-150, miR-152

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review